[PTX] YoY Annual Result on 30-Jun-2018 [#FY]

Stock
[PTX] Prescient Therapeutics Limited
Announcement Date
29-Jun-2018
Financial Year
2018
Quarter
30-Jun-2018 [#FY]
Profit Trend
YoY- -0.23%
Quarter Report
PTX's Result
PTX's Financial Summary
View:
Show?
Annual Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 1,185 1,029 1,648 940 1,224 1,003 251 29.49%
PBT -5,334 -4,351 -5,429 -3,514 -3,626 -1,754 -2,133 16.48%
Tax -1,185 -1,029 -1,631 -940 -1,058 -992 -53 67.76%
NP -4,149 -3,321 -3,797 -2,574 -2,568 -1,754 -2,133 11.71%
Tax Rate - - - - - - - -
Total Cost 5,334 4,351 5,445 3,514 3,792 2,757 2,384 14.35%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -349.97 -322.65 -230.45 -273.87 -209.73 -174.98 -849.66 -13.73%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.01 -0.01 -0.02 -0.01 -0.01 -0.02 -0.04 -20.61%
EPS Diluted -0.01 -0.01 -0.02 -0.01 -0.01 -0.02 -0.04 -20.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.